Topic: drug manufacturing


Overcoming Manufacturing Challenges for Accelerated Approvals

The pharmaceutical industry has experienced a trend in the number of accelerated approval designations for drugs (e.g. orphan drugs, breakthrough therapies, accelerated approvals, and FDA priority reviews) being developed.

New Drug Pricing Strategies for a Changing Global Market

During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues.